In a major step forward for blood pressure treatment, the US Food and Drug Administration (FDA) has approved WIDAPLIK, a new ...

A federal judge last year kneecapped the state’s effort to restrict groups touting the controversial treatment.

A final-stage clinical trial comparing a new long-acting, once-weekly pill to treat schizophrenia symptoms with the existing daily treatment has found that both produce comparable therapeutic effects.